Dr. Joel Schlessinger shares his thoughts on Valeant and Allergan with The Wall Street Journal
Valeant, a large manufacturer of commonly prescribed medicines and treatments, including many best-selling skin care and cosmeceutical products, is in the process of purchasing Allergan.
Dr. Schlessinger was recently quoted as an expert in his field in The Wall Street Journal. In the article, “Bid for Allergan Puts Valeant’s Research and Development Cuts Under Scrutiny” he discusses the new merging of Valeant and Allergan, the manufacturer of Obagi,products and the Restylane®, Perlane® and Dysport™ injectables.
Dr. Joel Schlessinger works with Valeant to create customer loyalty programs.
Recently, in response to a request from Dr. Schlessinger, the company employed a customer rebate program for cosmetic procedures. “Valeant may have trimmed in some areas, but the company has found other ways to appeal to patients and physicians, such as by rejiggering a patient loyalty program,” says Dr. Schlessinger.
We at LovelySkin are so proud of Dr. Schlessinger’s patient advocacy efforts! Valeant plans to continue to work with Dr. Schlessinger and other physicians to cultivate more great programs in the future.
Do you have a question for Dr. Schlessinger about Valeant and Allgeran? Let us know in the comments below.